Evercore ISI likes the expansion of pemvidutide into alcohol liver disease and alcohol use disorder as it adds another leg to the pemvidutide story and one that Altimmune (ALT) can take the lead ...

Evercore ISI notes that this marks the third high-profile executive to leave Arista in the last 18 months, which could lend some support to the bearish perspective on the company. However ...

Evercore ISI analyst Kirk Materne maintained a Buy rating on EverCommerce (EVCM – Research Report) on March 14 and set a price target of $13.00. The company’s shares closed last Friday at $9. ...

Prior to CEA, he was Managing Director and Head of Fiscal Analysis at Evercore ISI, a macro advisory firm. He was also previously an economist at the U.S. Department of the Treasury. Ernie ...

All of the securities sold in the offering were sold by Mineralys. BofA Securities, Evercore ISI, Goldman Sachs & Co. LLC, Stifel and Wells Fargo Securities acted as joint book-running managers ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CABA has been the topic of several analyst reports. Evercore ISI lowered Cabaletta Bio from an “outperform” rating to an “inline” rating and reduced their target price for the stock from $ ...

just by virtue of their size and by virtue of their importance," Evercore technical strategist Rich Ross told Yahoo Finance's Brian Sozzi on the Opening Bid podcast. US stocks dropped across the ...

"The near-term future of this market, for lack of a better term, is dictated by what's going on at Nvidia and really in semiconductors and technology writ large, just by virtue of their size and by ...

They use steroids in their trials. A lot. In a webinar hosted by Umer, an analyst at Evercore, during the ASH conference, he pointed out that Arcellx used steroids in a large majority of their ...